Newly identified drug targets could open door for esophageal cancer therapeutics
IMAGE: Graphical abstract of TGF-beta pathway activity during progression of esophageal adenocarcinoma. view more Credit: Case Western Reserve School of Medicine Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in the United States, according to new research out of Case Western Reserve University…